Multiple neoplasms, single primaries, and patient survival.

Area of Science:

• Oncology
• Cancer Epidemiology

Background:

• Multiple primary neoplasms are increasingly common in cancer survivors.
• The impact of multiple primary cancers on patient survival requires further definition.

Purpose of the Study:

• To analyze the clinical characteristics and survival outcomes of patients with single versus multiple primary neoplasms.
• To differentiate between simultaneous, synchronous, and metachronous secondary malignancies.

Main Methods:

• Retrospective review of clinical data for 1,873 histologically confirmed cancer patients (2005-2012).
• Categorization of second primary neoplasms based on discovery timing: simultaneous, synchronous (within 6 months), and metachronous (after 6 months).

Main Results:

• 322 of 1,873 patients developed second malignancies (284 with two, 38 with three or more).
• Patients with multiple primaries were more likely Caucasian (91.0%), had earlier stage disease (78.9%), and a strong family history (22.3%).
• Five-year survival was highest for metachronous cancers (95%), followed by synchronous (59%) and single primaries (59%).

Conclusions:

• Multiple primary cancer patients often present with less aggressive, earlier-stage disease and have a strong family history.
• These cancers tend to exhibit indolent behavior, leading to longer survival rates, potentially due to genetic factors.
• Metachronous primaries show significantly better survival than synchronous or simultaneous ones.